Last Friday the stock price jumped on a very low trading volume, you thought a good news is coming. Wrong, today the stock is down -14%, and welcoming more miserable bagholders who bought at high. You believe today is a good day to buy because it will go up tomorrow. Wrong, again! This will go down another 14% tomorrow. Soon this one-man company will go down in a sinking boat. The rat will walk away with salary money, leave nothing to long time bagholders.
Sentiment: Strong Sell
watch them sell free shares on days like this. who pays for their salaries that they really don't deserve: YOU SHAREHOLDERS.
Sentiment: Strong Sell
#$%$ like french has no guilty conscience nor remorse. he'll steal your money again while you're awake with eyes opened. READ THIS STATEMENT:
Effective as of the close of business on December 31, 2013, Philip C. Ranker resigned as the interim Chief Financial Officer and Secretary of the Company and Richard T. Ho, M.D., Ph.D. resigned as the Executive Vice President - Research & Development of the Company. In connection with such resignations, and in order to satisfy certain unfulfilled payment obligations in the aggregate amount of approximately $834,000 that were due to each of them pursuant to their respective employment agreements with the Company, the Company on January 1, 2014 agreed to issue to Mr. Ranker and Dr. Ho (after applying a discount to the amount owed) an aggregate of 1,257,000 shares of Common Stock. At the same time, and in order to satisfy certain unfulfilled payment obligations in the amount of approximately $415,000 that were due to J. Michael French pursuant to his employment agreement with the Company, the Company on January 1, 2014 agreed to issue to Mr. French (after applying a discount to the amount owed) 1,130,000 shares of Common Stock. Each share of Common Stock issued to Messrs. French and Ranker, and to Dr. Ho, was valued based on the volume weighted average price of the Common Stock for the ten trading days ending on December 31, 2013.
Sentiment: Strong Sell
hammertimeee, is that your real name? what comical name you have. french is a incompetent, but he's no fool when it comes to destroying shareholders' investment. his favorite trick is stunt shareholders with multiple stock reverse splits and dilutions. you will see soon, this man will pull the trigger. he implied it in his miserable talk he gave on the last day of miserable small-cap biotech conference. btw i hope he gets medicine for his chronic respiratory condition. it's revealing inner misery of this man!
i might add the presentation was as uninteresting, dull and painful as audibly loud sighs that the man is pathetically making.
probably not as pathetic as someone foolishly investing in this company. i pray that it's not you, or maybe you are as you're so delighted to defend it. btw, a couple of few minutes (not 10+10 as according you) i spent out of my day to reply to first poster's question is nothing compared to you becoming a long time bagholder ;)
anyone who is smart enough will immediately understand that his talk is all about pointless, badly put together chemistry textbook descriptions of patent technologies, and displaying chemical compound diagrams. there's no talk of actual clinical trial, medical analysis, but mostly talks of chasing dreams. the ceo is a pathetic, incompetent man who should have never managed a company. my advice is don't waste a penny and your precious time in this failed company.
this is what i think. the talk he gave is same old contents he used in his ancient time presentations years ago, which imply how old an outdated their patent portfolio is. it's a total useless garbage while similar peer companies are working on far better, effective, competitive, novel drug technologies and some have gained fda approvals. this company has a zero/nil chance of survival, they have no space in biotech pharmaceutical industry. if you know a little bit of this company's history, this incompetent ceo single-handedly destroyed the value of company by not delivering promises, mis-executions and series of stock reverse-splits to completely sabotage investors, who believed in the company. this company is a failure, and i guarantee you that no big pharmaceutical company will give them and this incompetent ceo a chance of investment. just wait a short time and watch this company completely disappear soon.
let me add one more. i strongly doubt they understand what they have in their patent portfolio. how the science & technology works behind those years of work & research findings. do they even have a team of competent scientists to know what they're going to do with all those patents. imo, the man really screwed up wasting capitals buying those patent rights.
if market expects a good thing from this man's presentation later today, pps should be up, not down. as of now, investors are down 8.9%. it shows mistrust in this man's ability to manage a micro-cap company. pathetic and incompetent.
there's one thing i agree you is how incompetent this man is. why didn't the board fire this man? it's hard to figure out, but i guess they're also incompetent as he is.
guys, guys, hahaha.. thanks for some good laughs. i was felling ill these days. you're all fantastic people lol
remember mm-121 did fail totally, it still showed efficacy in fps in n=57 subpopulation, meaning that science is still valuable and need to optimize for a improved clinical solution. it's a matter of trial-error repeated a number of times to perfect the method. mgmt needs to pull its #$%$ together to manage cost down.
i suspect a big announcement to be made around mid-december to early january '14 regarding mm-398. mgmt really needs to pull this together. stay tune for earning call next thursday. it's an important pivot for future stock direction.
it really is hard to predict what the future is going to look like. you see a lot of strange outcomes in biotech sector. when you expect the price to fall after negatives, stock price goes up huge, and vice versa. same for mack, but the uncertainty surrounding mm-398 will put pressure on stock until the next event. the management needs to start provide some guidance/news. the stock is down 20% already, and I put lower probability that it will repeat again tomorrow on no impending negative news this week. negative news is already out today, but the focus is shift to mm-398. so it's important that mgmt start talking. short term bounce: $3